Back

Epicardial adipose layer in the control of cardiomyocyte ion homeostasis: Persistent atrial fibrillation, and semaglutide regulations

28 August 2026 (11:21 - 11:33)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation: epidemiology, prevention, and clinical outcomes Cellular Electrophysiology ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Ms Rumeysa Basdas

Instituto de Investigacion Sanitaria de Santiago, Santiago de Compostela (Spain)

4 More presentations in this session

Presentation thumbnail
Impact of CPAP therapy adherence on atrial fibrillation recurrence and progression in patients with severe obstructive sleep apnea
Assistant Professor P. Kalaydzhiev (Sofia, BG)
Abstract Slides Video
Presentation thumbnail
Effects of integrated lifestyle management before pulmonary vein isolation on quality of life – results from the POP-AF RCT
Mr J. Vermeer (Eindhoven, NL)
Abstract Slides Video
Presentation thumbnail
Real-world outcomes of hospital-detected atrial fibrillation. Results from the Scotland-wide treatment & outcomes in atrial fibrillation: real-world data LINkaGe (STARLING) cohort study
Doctor T. Pana (Aberdeen, GB)
Presentation thumbnail
Prevention of incident atrial fibrillation in type 2 diabetes: nationwide target trial emulation of SGLT2 inhibitors versus GLP-1 receptor agonists
Doctor G. Tsaban (Rochester, US)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation: epidemiology, prevention, and clinical outcomes
Video

The Event

Event poster

ESC Congress 2026

28 August 2026 11:21 CET
You may be interested in
thumbnail
Congress Presentation
Epicardial adipose tissue-derived adipo-cytokines induce pro-oxidant and pro-remodeling responses in atrial endothelial cells: synergic inhibitory effects of SGLT2 inhibition and GLP-1R activation
29 August 2025
thumbnail
Congress Session
Electrophysiology, arrhythmias, and cardiac modelling
28 August 2026
thumbnail
Congress Session
What's new for GLP-1 agonist and SGLT2 inhibitor cardiovascular pharmacotherapy?
29 August 2025
thumbnail
Congress Session
Obesity, diet, and cardiac arrhythmias: mechanisms and clinical implications
5 April 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources